Cogent Biosciences COGT
NASDAQ COGT
$29.81 -1.83 (-5.78%)
As of: Nov 11, 2026 · 11:46 AM EST

Cogent Biosciences (COGT) Net Margin (2017 - 2020)

Updated

Cogent Biosciences' Net Margin came in at -950.43% for FY2020, down 808.94 percentage points from -141.49% in FY2019.

Analysis

Cogent Biosciences (COGT) Net Margin (2017 - 2020) Analysis & Trends

Going back to FY2017, Cogent Biosciences' Net Margin data covers 4 years.

  • Net Margin carries a three-year change of -644.72 percentage points (FY2017 to FY2020).
  • Per Business Quant, earlier years put Net Margin at -141.49% in FY2019 (+213.43 pp), -354.92% in FY2018 (-49.22 pp) and -305.71% in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Cogent Biosciences 5.50 Bn 2.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -16,020.19%
Jun 30, 2020 -1,400.19%
Mar 31, 2020 -86.67%
Dec 31, 2019 15.02%
Sep 30, 2019 -1,168.92%
Jun 30, 2019 -335.12%
Mar 31, 2019 -382.93%
Dec 31, 2018 -226.18%
Sep 30, 2018 -497.70%
Jun 30, 2018 -541.60%
Mar 31, 2018 -304.10%
Dec 31, 2017 -315.87%
Sep 30, 2017 -300.99%
Jun 30, 2017 -282.83%
Mar 31, 2017 -325.94%
API Access

Cogent Biosciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=COGT&period=max&api_key=YOUR_API_KEY